TheEdgeResearch
Home / Stocks / NVS

Novartis AG (NVS)

NYSE Healthcare Drug Manufacturers - General
$159.90 ▲ +3.74%
Market Cap
$305.10B
Sector
Healthcare
Industry
Drug Manufacturers - General
Beta
0.49
52-Wk Range
112.34-170.46
CEO
Vas Narasimhan
Country
CH
Currency
USD

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Open full interactive analysis & DCF →